U.S. Mortgage REITs Stock News

What Restaurant Brands International Stock Offers Investors Right Now Restaurant Brands International (NYSE:QSR) runs several large quick service restaurant chains and gives investors exposure to coffee, burgers, chicken and sandwich concepts across Canada, the United States and other international markets. The stock recently closed at US$74.41, with reported annual revenue of US$9.59b and net income of US$1.08b. This positions Restaurant Brands International as a sizeable player in global...

Grand Canyon Education (LOPE) has drawn fresh attention after recent share moves, with the stock roughly flat over the past month but down about 14% in the past 3 months. See our latest analysis for Grand Canyon Education. At a share price of $144.86, Grand Canyon Education has recently seen short term momentum pick up, with the 1 day share price return of 3.52% and 7 day share price return of 3.87% set against a weaker 1 year total shareholder return of 13.36% and stronger 3 and 5 year total...

Earlier in July 2026, Equinix, Inc. confirmed the planned departure of Chief Business Officer Jon Lin and outlined a transition plan distributing his responsibilities across the senior leadership team while preparing to appoint a new Chief Product Officer. Shortly afterward, the company named Chris Audie as Chief Product Officer and Bruce Owen as Executive Vice President, Global Markets, underscoring a sharpened focus on product innovation and global operations alignment. Next, we’ll examine...

Sarepta Therapeutics has appointed Michael Severino, M.D., a veteran of AbbVie, Amgen, Merck and most recently Tessera Therapeutics, as its Chief Executive Officer effective July 28, 2026, succeeding Douglas Ingram. By combining the CEO role with a seat on Sarepta’s board, Severino’s broad R&D and corporate strategy background could shape how the company prioritizes its gene therapy and RNA-based rare disease programs. Next, we’ll explore how bringing former AbbVie president Michael Severino...

After a 37.8% return over the past year, Best Buy stock no longer looks like an obvious bargain, and the current checks suggest pricing that is roughly in line with what its fundamentals support rather than clearly cheap or clearly expensive. The 37.8% one year gain puts recent shareholders in a strong position, which can make fresh entries more sensitive to what is already baked into the price. Leadership changes, including a new CEO and a chief fulfillment and operations officer focused on...

Rigetti Computing announced a partnership with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center to build TangleLab, a hybrid quantum‑classical supercomputing testbed at PSC, funded by a US$5.0 million National Science Foundation grant and scheduled to begin construction in 2026 with full operations targeted for 2027. This collaboration embeds Rigetti’s 9‑qubit Novera system in an open, federally backed research and education platform, potentially deepening its role in...

Earlier in July 2026, ACADIA Pharmaceuticals announced that the FDA granted Fast Track designation to remlifanserin, its investigational 5-HT2A inverse agonist for hallucinations and delusions in Alzheimer’s disease psychosis, alongside progress updates on the seamless Phase 2/3 RADIANT program. This designation, coupled with ongoing Phase 3 enrollment, highlights how remlifanserin could meaningfully expand ACADIA’s late-stage CNS portfolio beyond its current commercial drugs. Next, we’ll...

Uber Technologies has given investors a solid 56.8% return over the past five years, yet the stock has recently pulled back and now screens as undervalued on several key checks, putting fresh focus on whether the current price still reflects the underlying business. Over five years, Uber Technologies has returned 56.8%, which puts the recent share price weakness into context as part of a longer period of positive performance. New partnerships such as the GameStop delivery tie up and...

Tandem Diabetes Care (TNDM) stock has drawn attention after recent trading left it at a last close of $17.17, prompting investors to reassess its performance over the past month and past 3 months. See our latest analysis for Tandem Diabetes Care. At a share price of $17.17, Tandem Diabetes Care has seen a modest 30 day share price return of 5.73%. However, its year to date share price return is down 20.32%, and the 3 year total shareholder return is down 50.83%. This points to fading momentum...

Marvell Technology’s share price has delivered a very strong 218.2% return over the past 5 years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value pointing to a premium to current cash flow assumptions while market multiples still screen the stock as relatively inexpensive against peers. Over 5 years, Marvell Technology has returned 218.2%, which puts extra focus on whether today’s price is already baking in optimistic expectations. Recent enthusiasm...

Karman Holdings (NYSE:KRMN) is investing $2.7 million to expand its Horsham, Pa. facility. The expansion is intended to support advanced defense material technologies and US Navy operational readiness. The project is aligned with recent acquisitions and is expected to increase production capacity and high tech employment at the site. Karman Holdings operates in advanced materials and defense related technologies, a segment that sits at the intersection of national security priorities and...

Snowflake stock sits at the center of a clear valuation tension, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to roughly 41.0% upside relative to the market price, while market based multiples lean the other way and the broader checks flag the shares as far from a straightforward bargain. Snowflake has returned 53.6% over the past 3 years, which puts extra weight on whether current buyers are paying a premium for that track record. Recent AI focused...

Dime Commercial Bancshares, Inc. reported its second-quarter 2026 results with net interest income of US$115.19 million and net income of US$34.81 million, both higher than a year earlier, while also declaring a quarterly US$0.34375 dividend on its 5.50% Series A preferred stock payable on August 14, 2026. The combination of stronger core earnings and the continuation of preferred dividends highlights the bank’s capacity to support income-focused investors while reinforcing its capital...

With inflation, energy prices and central banks all pulling on your portfolio at once, steady dividend income can feel more valuable than ever. That is where Dividend Powerhouses with 5%+ yields and a track record of well covered, growing and stable payouts come in. This screener focuses on companies that put cash returns to shareholders at the centre of their story. This can help balance choppy markets and mixed growth signals across regions. In this article, you will see 3 of the strongest...

The new content partnership between NBCUniversal’s Peacock and YouTube Premium has pushed streaming distribution into fresh territory, and investors in digital entertainment are watching closely. By folding Peacock’s full library, including NFL and NBA rights, into YouTube Premium from early 2027, the deal links one of the largest video platforms with a growing subscription service. It also points to new ways of sharing content, advertising, and revenue across platforms. This article walks...

Earlier this week, Biohaven disclosed that a federal jury awarded the company US$1,000,000 in damages in a trade secret lawsuit against Avilar Therapeutics and RA Capital Management. The verdict underscores the legal weight behind Biohaven’s efforts to safeguard its intellectual property, a core asset for any research‑driven biopharmaceutical business. Next, we’ll examine how this courtroom win on intellectual property protection shapes Biohaven’s broader investment narrative over the coming...

New tariffs of 10% to 12.5% on nearly all US trade are shaking up global supply chains, and that puts a fresh spotlight on stocks with ties to domestic manufacturing and onshoring. For investors, the question is which companies might benefit from production rooted closer to home and which could face higher costs or pressure on margins as trade rules tighten. This article breaks down how the latest Section 301 tariffs could matter for your portfolio and profiles 3 stocks from our US Domestic...

In late July 2026, Alpha Metallurgical Resources reported preliminary second-quarter results indicating a net loss of US$12.3 million, or US$0.96 per diluted share, and cut its full-year 2026 metallurgical coal sales volume guidance while raising cost expectations amid market weakness and terminal equipment damage. At the same time, the company continued its capital return efforts, having repurchased 7,034,690 shares since March 2022 for US$1.17 billions, equal to very large portion of its...

Ohio Valley Banc (OVBC) has released its Q2 2026 results, with revenue of about US$14.8 million and EPS of roughly US$0.62, while trailing twelve month revenue sits at around US$62.4 million and EPS at about US$3.02, alongside net income of roughly US$14.2 million over that period. The company has seen quarterly revenue and EPS move within a relatively tight band over recent periods, from about US$16.2 million and US$0.89 in Q2 2025 to around US$14.8 million and US$0.62 in the latest quarter...

Costco Wholesale stock is coming off a strong run, with a 134.1% return over the past 5 years, yet its current valuation appears expensive rather than a clear bargain. Over 5 years, Costco Wholesale has returned 134.1%, which puts recent short-term moves into the context of a stock that has already rewarded long-term holders. Investor focus on Costco Wholesale's use of AI to improve inventory and supply chain efficiency can support expectations for resilient profitability. However,...

Ensign Group (ENSG) opened Q2 2026 with total revenue of US$1.4 billion and basic EPS of US$1.72, as part of a trailing twelve month profile that includes US$5.5 billion in revenue and EPS of US$6.57, alongside reported earnings growth of 17.3% over the past year. The company has seen revenue move from US$1.23 billion in Q2 2025 to US$1.44 billion in Q2 2026, with quarterly EPS rising from US$1.48 to US$1.72 over the same period. This sets up a results season in which net margin trends and...

Medtronic (MDT) is back in focus after initiating a voluntary Class II recall of its DLP One-Piece Pediatric Arterial Cannula, following two complaints about loose foreign material containing trace levels of blood. See our latest analysis for Medtronic. At a share price of US$84.22, Medtronic's recent 1 month share price return of 4.0% contrasts with a year to date share price return that is down 12.3%, while the 3 year total shareholder return of 5.9% points to relatively modest longer term...

In July 2026, Citigroup Inc. reported higher Q2 net interest income of US$17,125 million and net income of US$5,831 million year on year, alongside multiple long-dated bond offerings and detailed preferred stock dividend declarations, including plans to redeem US$1.50 billion of Series T preferred shares. While the earnings beat and increased common dividend highlight strong current profitability and capital return capacity, management’s emphasis on rising expenses and accelerated investment...

Liberty Global earnings and buyback update Liberty Global (LBTY.A) reported second quarter 2026 results that showed a smaller net loss alongside slightly lower sales, coinciding with an update on its long running multi year share repurchase program. For the second quarter ended June 30, 2026, the company reported sales of US$1,172 million compared with US$1,269.1 million in the same period a year earlier. Net loss for the quarter was US$365.1 million compared with US$2,792.9 million a year...